AbbVie Inc. Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount
AbbVie Inc. (ABBV) reported Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount of $187.00 million for the 3-month period ending 2016-12-31, per its 10-K filed 2018-02-16.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings · last filed 2019-02-27
- AbbVie Inc. effective income tax rate reconciliation, repatriation of foreign earnings, amount for the quarter ending 2016-12-31 was $187.00M.
| Period end | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount 3 month |
|---|---|---|
| 2016-12-31 | $187.00M 10-K · filed 2018-02-16 | |
| 2016-12-07 | $187.00M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |